PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsdysmenorrhea
MeSH D004412 - dysmenorrhea
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D017699:Pelvic pain
0 Companies
0 Drugs
Success rate
D008599:Menstruation disturbances
$
Success rate
D004412: 
Dysmenorrhea
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Abbott BiotherapeuticsIbuprofen Ibu  1989-12-18   
Ibuprofen Ibuprofen  1985-06-14   
AbbVieIbuprofen, Hydrocodone Vicoprofen  1997-09-23   
Able LaboratoriesNaproxen Naproxen  2003-08-22   
Ajanta PharmaNaproxen, Esomeprazole strontium Naproxen Esomeprazole Magnesium  2022-10-06   
AkornDiclofenac Diclofenac  2008-04-17   
Alembic PharmaceuticalsDiclofenac Diclofenac  2022-07-27   
Alkem LaboratoriesIbuprofen Ibuprofen  2021-09-13   
Famotidine, Ibuprofen Ibuprofen Famotidine  2021-08-03   
AllerganNaproxen Naproxen  1995-02-10   
Naproxen, Esomeprazole strontium Naproxen Esomeprazole Magnesium  2022-08-24   
Diclofenac Diclofenac  1996-03-26   
Diclofenac, Misoprostol Diclofenac Misoprostol  2012-07-09   
Ibuprofen, Hydrocodone Hydrocodone Ibuprofen  2003-12-31   
Ibuprofen Ibuprofen  1985-09-06   
Oxycodone, Ibuprofen Oxycodone Ibuprofen  2007-11-26   
1
2
3
4
5
6
...
15
>
Clinical Trials
Historical Success Rate
Phase 1
50%
2/4
Phase 2
58%
11/19
Phase 3
83%
29/35
Approved: 12Overall Success rate: 24%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Abbott Biotherapeutics
Akorn
1
2
3
4
5
6
...
10
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use